Entrada Therapeutics
Price & Volume
Stats
See more52W Range | $4.93-$14.27 |
Market Cap | $420.4M |
Shares Short | 760,344 |
Financials
See moreRevenue (12 Mos) | $61.5M |
Revenue Growth (YoY) | -91.8% |
Gross Profit (12 Mos) | -$80.1M |
Diluted EPS | -$2.57 |
News
See moreYahoo Finance • last month
Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Yahoo Finance • last month
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 4 months ago
Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program
Yahoo Finance • 5 months ago
Entrada Therapeutics Inc (NASDAQ:TRDA) Reports Q2 2025 Earnings Miss, Shares Drop in Pre-Market Trading
About
CEO | Mr. Dipal Doshi |
CFO | Mr. Kory James Wentworth CPA |
Address | One Design Center Place, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 183 |
